Literature DB >> 22970047

The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines.

Chong Yan1, Chibo Liu, Qiaozhi Jin, Zhihai Li, Baohong Tao, Zhiyi Cai.   

Abstract

The aim of this study was to investigate the mRNA and protein expression levels of the Syk gene as well as its promoter methylation in nasopharyngeal carcinoma (NPC) cell lines. The CNE-1 (highly differentiated), CNE-2 (poorly differentiated) and NP69 (non-cancerous human immortalized nasopharyngeal epithelial cells) cell lines were used in the present study. The MS-PCR, Q-RT-PCR and western blotting methods were used to examine the Syk gene promoter methylation levels and mRNA and protein expression in the three cell lines. The promoter methylation levels in CNE-1, CNE-2 and NP69 cells were 36%, 62% and 0, respectively. The mRNA levels in CNE-1 and CNE-2 cells were 42±3.5 and 28±2% of that in NP69, respectively; the protein levels in CNE-1 and CNE-2 cells were 36±4.5 and 16±2.5 of that in NP69, respectively; the statistical differences between groups were significant. The lower differentiation levels of the NPC cell lines correlate with lower levels of mRNA and protein expression of the Syk gene, as well as higher promoter methylation levels.

Entities:  

Year:  2012        PMID: 22970047      PMCID: PMC3439144          DOI: 10.3892/ol.2012.763

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

Review 1.  Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.

Authors:  Qian Tao; Anthony T C Chan
Journal:  Expert Rev Mol Med       Date:  2007-05-04       Impact factor: 5.600

2.  Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis.

Authors:  T Taniguchi; T Kobayashi; J Kondo; K Takahashi; H Nakamura; J Suzuki; K Nagai; T Yamada; S Nakamura; H Yamamura
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

Review 3.  Molecular biology and genetics of breast cancer development: a clinical perspective.

Authors:  Thomas A Buchholz; David E Wazer
Journal:  Semin Radiat Oncol       Date:  2002-10       Impact factor: 5.934

Review 4.  Genetic and epigenetic changes in nasopharyngeal carcinoma.

Authors:  Kwok-Wai Lo; Dolly P Huang
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

Review 5.  The Syk kinase as a therapeutic target in leukemia and lymphoma.

Authors:  Dimitar G Efremov; Luca Laurenti
Journal:  Expert Opin Investig Drugs       Date:  2011-03-26       Impact factor: 6.206

6.  Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.

Authors:  Susanna H Hutajulu; Sagung R Indrasari; Luh P L Indrawati; Ahmad Harijadi; Sylvia Duin; Sofia M Haryana; Renske D M Steenbergen; Astrid E Greijer; Jaap M Middeldorp
Journal:  Mol Cancer       Date:  2011-05-02       Impact factor: 27.401

Review 7.  Syk: a new player in the field of breast cancer.

Authors:  Z A Stewart; J A Pietenpol
Journal:  Breast Cancer Res       Date:  2000-11-02       Impact factor: 6.466

Review 8.  Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.

Authors:  Sandrine Medves; Jean-Baptiste Demoulin
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

9.  Nasopharyngeal carcinoma as a paradigm of cancer genetics.

Authors:  Malcolm J Simons
Journal:  Chin J Cancer       Date:  2011-02

Review 10.  Epigenetic disruption of cell signaling in nasopharyngeal carcinoma.

Authors:  Li-Li Li; Xing-Sheng Shu; Zhao-Hui Wang; Ya Cao; Qian Tao
Journal:  Chin J Cancer       Date:  2011-04
View more
  3 in total

1.  Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report.

Authors:  Hui Peng; Jun Huang; Ying Hu; Yisheng Wei; Huanliang Liu; Meijin Huang; Lei Wang; Jianping Wang
Journal:  Cell Oncol (Dordr)       Date:  2015-04-29       Impact factor: 6.730

2.  Histone methyltransferase DOT1L mediates the TGF-β1/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction.

Authors:  Fei Li; Lei Li; Jiacheng Zhang; Xuesong Yang; Yang Liu
Journal:  Hum Cell       Date:  2021-10-11       Impact factor: 4.174

3.  Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression.

Authors:  Beibei Ni; Jun Hu; Dianke Chen; Li Li; Daici Chen; Jianping Wang; Lei Wang
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.